(1R,2R)-N,1-dihydroxy-2-[({4-[(2-methylquinolin-4-yl)methoxy]phenyl}sulfonyl)amino]cyclopentanecarboxamide

ID: ALA4071465

PubChem CID: 11856418

Max Phase: Preclinical

Molecular Formula: C23H25N3O6S

Molecular Weight: 471.54

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cc1cc(COc2ccc(S(=O)(=O)N[C@@H]3CCC[C@]3(O)C(=O)NO)cc2)c2ccccc2n1

Standard InChI:  InChI=1S/C23H25N3O6S/c1-15-13-16(19-5-2-3-6-20(19)24-15)14-32-17-8-10-18(11-9-17)33(30,31)26-21-7-4-12-23(21,28)22(27)25-29/h2-3,5-6,8-11,13,21,26,28-29H,4,7,12,14H2,1H3,(H,25,27)/t21-,23-/m1/s1

Standard InChI Key:  ZYWDGGHUEGUMLY-FYYLOGMGSA-N

Molfile:  

     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
    7.5749   -9.6915    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9915  -10.4081    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.4038   -9.6889    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.8484   -9.5706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8472  -10.3979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5620  -10.8108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5602   -9.1578    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.2756   -9.5670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2764  -10.3938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9916  -10.8048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7067  -10.3901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7019   -9.5600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9860   -9.1529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1338   -9.1583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5640  -11.6358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8504  -12.0499    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.1351  -11.6392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1378  -10.8149    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4232  -10.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7087  -10.8183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7132  -11.6476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2798  -10.8236    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2828  -11.6486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6224  -12.1360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8802  -12.9197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7052  -12.9166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9572  -12.1311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2040  -11.4165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6144  -10.7008    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3791  -11.4190    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9644  -10.7057    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.8207  -12.3456    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4300  -12.0561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  4 14  1  0
  6 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 33 17  1  0
 20  2  1  0
  2 22  1  0
 23 22  1  6
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 23  1  0
 24 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 24 32  1  1
 21 33  2  0
M  END

Alternative Forms

1. Parent:

   

   ALA4071465

   (1R,2R)-N,1-dihydroxy-2-[({4-[(2-methylquinolin-4-yl)methoxy]phenyl}sulfonyl)amino]cyclopentanecarboxamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 471.54

Molecular Weight (Monoisotopic): 471.1464

AlogP: 2.19

#Rotatable Bonds: 7

Polar Surface Area: 137.85

Molecular Species: NEUTRAL

HBA: 7

HBD: 4

#RO5 Violations: ┄

HBA (Lipinski): 9

HBD (Lipinski): 4

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 8.57

CX Basic pKa: 5.02

CX LogP: 1.83

CX LogD: 1.80

Aromatic Rings: 3

Heavy Atoms: 33

QED Weighted: 0.31

Np Likeness Score: -0.62

References

1. Ouvry G, Berton Y, Bhurruth-Alcor Y, Bonnary L, Bouix-Peter C, Bouquet K, Bourotte M, Chambon S, Comino C, Deprez B, Duvert D, Duvert G, Hacini-Rachinel F, Harris CS, Luzy AP, Mathieu A, Millois C, Pascau J, Pinto A, Polge G, Reitz A, Reversé K, Rosignoli C, Taquet N, Hennequin LF..  (2017)  Identification of novel TACE inhibitors compatible with topical application.,  27  (8): [PMID:28274635] [10.1016/j.bmcl.2017.02.035]

Source

Source(1):

• Scientific Literature